Home > Pharmaceutical > Neurodegenerative Disease

Neurodegenerative Disease (201)

OTC Drug (123)

Pharmaceutical Companies (387)

Prescription Drugs (312)

Regulation (237)

Vaccines (150)

Veterinary Medicine (30)

Neurodegenerative Disease Market Research Reports

We offer market research, industry forecasts, and business analysis in the Neurodegenerative Disease as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis.

Filter

Title Search

1 - 25 of 201 Products

Sort by

Display

Multiple Sclerosis: KOL Insight Product code:273171
Published by	Doctor's Guide Publishing Limited (FirstWord Pharma)
Published	May 29, 2013	Content info	135 Pages
Price	US $ 4995

Global Alzheimer's Drugs Market 2012-2016 Product code:273286
Published by	Infiniti Research Limited (Technavio)
Published	May 24, 2013	Content info	51 Pages
Price	US $ 2500

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets Product code:105600
Published by	BCC Research
Published	May 17, 2013	Content info	179 pages
Price	US $ 5450

Central Nervous System Disorder Treatment Drugs Markets in China Product code:100219
Published by	Asia Market Information & Development
Published	May 1, 2013	Content info	185 Pages
Price	US $ 2000

Drug Delivery in Central Nervous System Diseases - technologies, markets and companies Product code:70934
Published by	Jain Pharmabiotech
Published	May 1, 2013	Content info
Price	US $ 3000

Alzheimer disease - new drugs, markets and companies Product code:70927
Published by	Jain Pharmabiotech
Published	May 1, 2013	Content info
Price	US $ 3500

Neuroprotection - Drugs, Markets and Companies Product code:70919
Published by	Jain Pharmabiotech
Published	May 1, 2013	Content info
Price	US $ 5000

Alzheimer Disease Treatment Drugs Markets in China Product code:86316
Published by	Asia Market Information & Development
Published	April 15, 2013	Content info	207 Pages
Price	US $ 2000

Tcelna (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Product code:270245
Published by	GlobalData
Published	March 31, 2013	Content info	60 Pages
Price	US $ 3495

NU-100 (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Product code:270244
Published by	GlobalData
Published	March 31, 2013	Content info	60 Pages
Price	US $ 3495

Siponimod (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Product code:270243
Published by	GlobalData
Published	March 31, 2013	Content info	61 Pages
Price	US $ 3495

Masitinib (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Product code:270242
Published by	GlobalData
Published	March 31, 2013	Content info	60 Pages
Price	US $ 3495

Daclizumab (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Product code:270241
Published by	GlobalData
Published	March 31, 2013	Content info	61 Pages
Price	US $ 3495

Ocrelizumab (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Product code:270240
Published by	GlobalData
Published	March 31, 2013	Content info	61 Pages
Price	US $ 3495

Laquinimod (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Product code:270239
Published by	GlobalData
Published	March 31, 2013	Content info	62 Pages
Price	US $ 3495

Lemtrada (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Product code:270238
Published by	GlobalData
Published	March 31, 2013	Content info	63 Pages
Price	US $ 3495

BG-12 (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Product code:270237
Published by	GlobalData
Published	March 31, 2013	Content info	62 Pages
Price	US $ 3495

Aubagio (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Product code:270236
Published by	GlobalData
Published	March 31, 2013	Content info	61 Pages
Price	US $ 3495

Gilenya (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Product code:270235
Published by	GlobalData
Published	March 31, 2013	Content info	48 Pages
Price	US $ 3495

Tysabri (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Product code:270234
Published by	GlobalData
Published	March 31, 2013	Content info	48 Pages
Price	US $ 3495

Rebif (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Product code:270233
Published by	GlobalData
Published	March 31, 2013	Content info	47 Pages
Price	US $ 3495

Copaxone (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Product code:270232
Published by	GlobalData
Published	March 31, 2013	Content info	49 Pages
Price	US $ 3495

Avonex (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Product code:270231
Published by	GlobalData
Published	March 31, 2013	Content info	48 Pages
Price	US $ 3495

Betaseron/Betaferon (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Product code:270230
Published by	GlobalData
Published	March 31, 2013	Content info	48 Pages
Price	US $ 3495

PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022 Product code:270228
Published by	GlobalData
Published	March 31, 2013	Content info	154 Pages
Price	US $ 4995

User Guide About Us Policies Site Map

Int'l: +1-860-674-8796 US: +1-866-353-3335 (Toll Free) | EU: +32-2-535-7543 | SG: +65-6223-2436